m.nascimento
TL2 · Oulu
Contributes reviews on supplier material. Based in Oulu.
Joined 14 April 2025 · last posted 21h
76Posts here
0Topics
0Solutions
1.7kLikes received
1.2kLikes given
21Badges
244Days visited
5kPosts read
Most-liked posts
-
Trifluoroacetate content and its consequences Replied, post #49 · Analytics › Impurities & related substances · 30 Jan 2026 · 32 likes This settles it for me, at least until somebody posts a reason it should not.
-
Scheduled maintenance and what will be unavailable Replied, post #61 · Meta › Announcements · 4 Mar 2025 · 31 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #3 · Compounds › Oral incretins · 18 Mar 2026 · 30 likes The opening post is right about the mechanism and I think understates the practical bit. Missed doses behave differently for a daily oral than for a weekly injection.…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #118 · Practice › Dosing & titration · 21 Feb 2026 · 30 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Alcohol: what is documented and what is folklore Replied, post #39 · Practice › Interactions · 3 Jun 2026 · 28 likes I had written a reply contradicting post #35 and deleted it. Here is what survived. Taking alcohol seriously for a moment rather than deflecting: the honest position is…
-
Reading SURMOUNT-1 without the press release Replied, post #58 · Compounds › Tirzepatide · 7 Nov 2025 · 28 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Basic User | bronze | 15 Apr 2025 |
| Read the Guidelines | bronze | 19 Apr 2025 |
| First Reply | bronze | 22 Apr 2025 |
| First Quote | bronze | 25 Apr 2025 |
| First Link | bronze | 27 Apr 2025 |
| Asked Well | bronze | 29 Apr 2025 |
| Welcome | bronze | 2 May 2025 |
| Member | bronze | 4 Jun 2025 |
| First Tag | bronze | 4 Jun 2025 |
| Sourced | bronze | 8 Jun 2025 |
| Reader | bronze | 1 Jul 2025 |
| Consistently Generous | silver | 3 Jul 2025 |
| Generous | bronze | 13 Jul 2025 |
| Editor | bronze | 25 Jul 2025 |
| Nice Post | bronze | 24 Aug 2025 |
| Good Post | silver | 13 Oct 2025 |
| First Vendor Report | bronze | 11 Nov 2025 |
| Popular Link | silver | 14 Jan 2026 |
| Thank You | silver | 17 Jan 2026 |
| Gives Back | gold | 24 Mar 2026 |
| Anniversary | silver | 14 Apr 2026 |